Home About Us Contact Us
CMEweb.com
All CoursesCourses by TopicCourses by SpecialtyCourses by Specialty CreditRegister Now!!
Register Now!!
Member Login
Your Account
Your Test History
Your Certificates
Your Payment History
All Courses
Courses by Topic
Courses by Specialty
Courses by Specialty Credit
Accreditation
State Requirements
FAQs
 
Home : Advanced Search : Course view






OB/GYN Clinical Alert (Vol. 33, No. 9) – January 2017


Specialty: OB/GYN Format: Text 
Course #: 13962  Price: $40.50  
Release date: 2016-12-14  Valid through: 2020-01-31  
Publication: This activity appeared in OB/GYN Clinical Alert, published on 2017-01-01. 
Course viewing requirements  (opens in a new window)
Instructions for Course Participation  (opens in a new window)
Legal disclaimer  (opens in a new window)


Release date: January 2017

Valid through: January 2020

Target Audience

This activity is intended for the obstetrician and gynecologist and nurses in OB/GYN practices.

Subjects

  • The Best Medical Treatment for Endometriosis? The Debate Continues
  • The Effect of Major Depression on Quality of Life After Surgery for Stress Urinary Incontinence
  • When to Start Progestin-only Contraceptives After Medical Abortion
  • Extending Life of LARCs: More Years for Your Implant

Objectives

  • Explain the latest data regarding diagnosis and treatment of various diseases affecting women
  • Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
  • Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credits

Nurses

  • Maximum of 2.25 nursing contact hours

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Jeffrey T. Jensen, MD, MPH, Leon Speroff Professor and Vice Chair for Research, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland

Robert W. Rebar, MD, Professor and Chair, Department of Obstetrics and Gynecology, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo

Chiara Ghetti, MD, Associate Professor, Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Washington University School of Medicine, St. Louis

Rebecca H. Allen, MD, Associate Professor, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, RI

Editors

Medical Editor: Jeffrey T. Jensen, MD, MPH

Peer Reviewer: Catherine Leclair, MD

Nurse Planner: Marci Messerle Forbes, RN, FNP

Nurse Planner: Andrea O’Donnell, RN, FNP

AHC Media Executive Editor: Leslie G. Coplin

Assistant Editor: Jonathan Springston

Financial Disclosure

Jeffrey T. Jensen, MD, MPH reports he is a consultant for Teva Pharmaceuticals, Microchips, and Evofem; and is a consultant for and receives grant research support from Bayer Healthcare, Merck, Agile Pharm, Population Council, AbbVie, ContraMed, and FHI360; and receives grant/research support from HRA Pharma and Medicines 360. Rebecca H. Allen reports she is a Nexplanon trainer for Merck and a Liletta trainer for Actavis, and she has served on advisory boards for Bayer and Pharmanest. Robert W. Rebar, MD and Chiara Ghetti, MD report no financial relationships relevant to this field of study.

OB/GYN Clinical Alert's Editor, Jeffrey T. Jensen, MD, MPH, reports he is a consultant for Teva Pharmaceuticals, Microchips, and Evofem; and is a consultant for and receives grant research support from Bayer Healthcare, Merck, Agile Pharm, Population Council, AbbVie, ContraMed, and FHI360; and receives grant/research support from HRA Pharma and Medicines 360.

Peer Reviewer Catherine Leclair, MD, Nurse Planners Marci Messerle Forbes, RN, FNP, and Andrea O’Donnell, RN, FNP, Executive Editor Leslie G. Coplin, and Assistant Editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2017, AHC Media. All rights reserved.



You are not currently logged in.
  • To view content articles and access course testing and evaluation, please login or register now

 


For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com.